Nuvectis Pharma Inc.
Filed as NUVECTIS PHARMA INC (COM), Equity As of 2026 Q2 among managers we track
- 2 Owners
- Max 0.6%
- $4M
- 2 new
In 2026 Q2 David Witzke and Nathan Fischel opened positions in Nuvectis Pharma.
Who owns this now
Largest portfolio weights among holders, up to 0.6% (David Witzke, Avidity Partners Management). Not free-float ownership.
Holders
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| David Witzke, Avidity Partners Management | New 0.59% | 200,000 | $3.7M | History | |
| Nathan Fischel, Dafna Capital Management | New 0.07% | 20,000 | $368K | History |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.